The BioDiscovery group will be contending for Israel's third biotechnology incubator project, TheMarker has learned. The Ministry of Industry and Trade wants to set up a third biotechnology incubator, beyond the two in Jerusalem and Rehovot. This third incubator will be set up in Omer, a southern town adjacent to Beer Sheba. The decision fell after the group decided that Israel's biotechnology industry had enough attractive investment opportunities for three special incubators, BioDiscovery leader Professor Max Hertzberg told TheMarker today. Hertzberg is currently holding meetings outside Israel with companies associated with BioDiscvery Israel. BioDiscovery had lost the ministry's last incubator tender, but it had good company. Another loser was the Lapid Biotechnology group, including giant Johnson & Johnson (NYSE:JNJ), and Israel's Teva Pharmaceuticals (Nasdaq:TEVA). The Rad BioScience group headed by the Zisapel brothers won the tender to build the incubator in Jerusalem, and the Einav group, headed by the Ofer brothers, won the Rehovot incubator project. The Lapid group has reportedly decided it will not participate in this third tender. It is launching an independent biotechnology endeavor. BioDiscovery Israel includes the Rothschild banking group and the Pasteur Institute of France. It also includes Israeli industrialist Stef Wertheimer and Morris Kahn, former controlling shareholder of Amdocs (NYSE:DOX) and the Aurec investment group.